SAREPTA THERAPEUTICS, INC. Accounts Payable
SAREPTA THERAPEUTICS, INC. (SRPT) had Accounts Payable of $50.98 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $50.98M.
- 2026-03-31: Accounts Payable, Current $70.38M.
- 2025-12-31: Accounts Payable, Current $280.84M.
- 2025-09-30: Accounts Payable, Current $94.02M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $50.98M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $70.38M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $280.84M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $94.02M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $136.70M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $156.10M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $214.44M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $118.77M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $107.42M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $91.54M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $164.92M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $87.95M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $109.80M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $106.71M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $95.88M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $118.46M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $56.21M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $54.01M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $76.74M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $44.16M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $76.68M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $76.65M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $111.09M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $74.53M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $91.66M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $26.59M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $68.09M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $81.95M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $44.05M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $26.50M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $33.83M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $20.41M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $17.38M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $17.38M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $8.47M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $5.32M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $10.92M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $27.45M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $29.69M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $20.68M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $17.13M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $18.67M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $20.23M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $7.43M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $14.10M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $9.32M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $12.41M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $967.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.31M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $7.72M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $8.08M 10-K · filed 2015-02-26 | $17.63M 10-K · filed 2014-03-03 |
| 2013-09-30 | $8.13M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $6.73M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $7.07M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $7.53M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $4.33M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $8.81M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $8.20M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $9.40M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $7.90M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $10.97M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $1.31M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |